"Plasma Exchange" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Removal of plasma and replacement with various fluids, e.g., fresh frozen plasma, plasma protein fractions (PPF), albumin preparations, dextran solutions, saline. Used in treatment of autoimmune diseases, immune complex diseases, diseases of excess plasma factors, and other conditions.
| Descriptor ID |
D010951
|
| MeSH Number(s) |
E02.095.135.750
|
| Concept/Terms |
Plasma Exchange- Plasma Exchange
- Exchange, Plasma
- Exchanges, Plasma
- Plasma Exchanges
|
Below are MeSH descriptors whose meaning is more general than "Plasma Exchange".
Below are MeSH descriptors whose meaning is more specific than "Plasma Exchange".
This graph shows the total number of publications written about "Plasma Exchange" by people in this website by year, and whether "Plasma Exchange" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 1 | 0 | 1 |
| 2000 | 0 | 1 | 1 |
| 2004 | 0 | 1 | 1 |
| 2007 | 0 | 1 | 1 |
| 2009 | 0 | 1 | 1 |
| 2012 | 0 | 1 | 1 |
| 2013 | 0 | 2 | 2 |
| 2015 | 1 | 0 | 1 |
| 2017 | 0 | 1 | 1 |
| 2018 | 2 | 0 | 2 |
| 2020 | 1 | 0 | 1 |
| 2021 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Plasma Exchange" by people in Profiles.
-
Therapeutic plasma exchange in acute fatty liver of pregnancy: a case report and literature review. Pan Afr Med J. 2021; 40:220.
-
Efficacy of therapeutic plasma exchange in the treatment of penn class 3 and 4 cytokine release syndrome complicating COVID-19. Respir Med. 2020 12; 175:106188.
-
Efficacy of therapeutic plasma exchange on angiotensin II type-1 receptor antibodies on two kidney transplant recipients. J Clin Apher. 2018 Dec; 33(6):673-677.
-
Plasma exchange to remove heparin-induced thrombocytopenia antibodies and the use of heparin during cardiopulmonary bypass in critically ill cardiac patients. J Heart Lung Transplant. 2018 08; 37(8):1038-1040.
-
Implementation of a rapid assay of ADAMTS13 activity was associated with improved 30-day survival rate in patients with acquired primary thrombotic thrombocytopenic purpura who received platelet transfusions. Transfusion. 2017 08; 57(8):2045-2053.
-
Poor responder to plasma exchange therapy in acquired thrombotic thrombocytopenic purpura is associated with ADAMTS13 inhibitor boosting: visualization of an ADAMTS13 inhibitor complex and its proteolytic clearance from plasma. Transfusion. 2015 Oct; 55(10):2321-30.
-
Acute antibody-mediated rejection in pediatric kidney transplants: a single center experience. Pediatr Transplant. 2013 Nov; 17(7):E149-55.
-
Kidney-limited thrombotic microangiopathy in patients with SLE treated with romiplostim. Lupus. 2013 Apr; 22(5):504-9.
-
Outcomes of patients with multiple myeloma and renal impairment treated with bortezomib, cyclophosphamide, and dexamethasone without plasma exchange. Eur J Haematol. 2012 Nov; 89(5):432-4.
-
Ticlopidine- and clopidogrel-associated thrombotic thrombocytopenic purpura (TTP): review of clinical, laboratory, epidemiological, and pharmacovigilance findings (1989-2008). Kidney Int Suppl. 2009 Feb; (112):S20-4.